ISAR Summit is a Summit of Innovative Technology that shall redefine the performance of drug-eluting stents as it contains Probucol which is a highly lipophilic drug and it retards the release of the drug thus ensuring proper endothelization, Microporous surface acts as a reservoir for delivering a drug to the targeted site and Everolimus which is a well-studied drug with higher bioavailability in target tissues.